SEC Form 3 · accession 0001078782-16-003004
NEXUS BIOPHARMA INC · NEXS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Warren C Lau
Officer — CEO, CFO, President, Secretary · Director · 10% Owner
Period of report
Jun 9, 2016
Accepted (ET)
Jun 20, 2016 · 1:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001424151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 7,899,741 | D |
Table II — derivative securities
No Table II lines on this filing.